• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Strategies for Prevention and Screening of CRM Conditions

Opinion
Video

Experts in cardiometabolic risk management explore strategies for the prevention and screening of cardiometabolic conditions.

Video content above is prompted by the following:

  • What does a successful CRM prevention or screening program look like in practice?
  • Can early intervention in patients with HF or T2D prevent CKD or vice versa?
  • How can early screening for CKD be improved and effectively implemented across different healthcare settings?
  • What specific steps can healthcare providers take to incentivize early screening and intervention for CRM conditions?
  • How can payers structure their reimbursement models to incentivize early detection and management of conditions like CKD, HF, and T2D?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.

Related Videos
1 expert is featured in this series.
5 experts are featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.